CD274 and neoplasm: Patients with gastric cancer categorized in the low cuproptosis-related prognosis signature subgroup exhibited elevated levels of tumor mutation burden (TMB), a higher incidence of MSI-H, and increased expression of PD-L1 in tumor (48).